945565-37-7Relevant articles and documents
The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain
Angus, Derek,Bingham, Matilda,Buchanan, Dawn,Dunbar, Neil,Gibson, Linsday,Goodwin, Richard,Hauns?, Anders,Houghton, Andrea,Huggett, Margaret,Morphy, Richard,Napier, Susan,Nimz, Olaf,Passmore, Joanna,Walker, Glenn
, p. 271 - 275 (2011)
Hit compound 1, a selective noradrenaline re-uptake transporter (NET) inhibitor was optimised to build in potency at the serotonin re-uptake transporter (SERT) whilst maintaining selectivity against the dopamine re-uptake transporter (DAT). During the opt